Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Overview
Authors
Affiliations
Purpose: To investigate sectoral differences in the relationship between optic nerve head tissue blood flow, anatomically corresponding visual field defect severity, and future progression.
Methods: This retrospective longitudinal medical chart review comprised 508 eyes of 319 open-angle glaucoma patients (mean deviation: -9.2 ± 7.0 dB), followed for an average of 4.7 ± 1.1 years; an average 11.7 ± 3.7 visual field tests were performed. Average total deviation (TD) was calculated in the superior, central, and inferior sectors of the Humphrey 24-2 program. The optic nerve head was divided to obtain inferior, temporal, and superior tissue-area mean blur rate (MT), derived from laser speckle flowgraphy. At baseline, the correlation between MT and TD was compared in anatomically corresponding sectors. We performed a multivariate analysis to determine the contribution of baseline MT to corresponding TD slope and to determine background factors influencing superior to temporal MT. We used a linear-mixed effect model for the statistical analysis.
Results: At baseline, the highest β coefficients were found between MT-superior and TD-inferior, MT-temporal and TD-central, and between MT-inferior and TD-superior, in that order (β = 0.38, β = 0.27, β = 0.26, respectively). MT-superior and MT-temporal independently contributed to corresponding TD slope (P < 0.05). Male sex, high body mass index, and the prevalence of sleep apnea syndrome were contributing factors to lower superior to temporal MT (P < 0.05).
Conclusions: Review of medical history, measurements of systemic variables, and laser speckle flowgraphy parameters might help clinicians to predict visual field defect severity and progression.
Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study.
Hanyuda A, Raita Y, Ninomiya T, Hashimoto K, Takada N, Sato K Invest Ophthalmol Vis Sci. 2024; 65(13):44.
PMID: 39565301 PMC: 11583989. DOI: 10.1167/iovs.65.13.44.
Takeda Y, Hanyuda A, Takahashi N, Omodaka K, Ninomiya T, Kiyota N Sci Rep. 2024; 14(1):26329.
PMID: 39487183 PMC: 11530458. DOI: 10.1038/s41598-024-76187-2.
Yamaguchi C, Kiyota N, Himori N, Omodaka K, Tsuda S, Nakazawa T Acta Ophthalmol. 2024; 103(1):e49-e57.
PMID: 39136108 PMC: 11704823. DOI: 10.1111/aos.16747.
Takahashi N, Omodaka K, Kikawa T, Ninomiya T, Kiyota N, Tsuda S Jpn J Ophthalmol. 2024; 68(4):311-320.
PMID: 38814490 PMC: 11349863. DOI: 10.1007/s10384-024-01071-5.
Ninomiya T, Kiyota N, Sharma P, Omodaka K, Himori N, Yasuda M Ophthalmol Sci. 2024; 4(2):100387.
PMID: 38524379 PMC: 10960060. DOI: 10.1016/j.xops.2023.100387.